Tripterygium |
Tripterygium glycosides |
Reduce 24-h UP, UAER and urinary β2-microglobulin |
Up-regulate autophagy through mTOR/Twist1, inhibit TLR4/NF-κB to decrease EMT and apoptosis/PI3K/Akt, immune-inflammatory [60–63] |
|
Triptolide |
Polyphenols |
Puerarin |
Reduce UAER and SCr |
RAGE pathway, regulate SIRT1 to induce autophagy and reduce PKC activity [65–68] |
|
Breviscapinun |
Reduce 24-h UP, SCr, BUN, and elevate TC and TG to decrease dyslipidemia |
Regulate the Nrf2 /HO-1, TGF-β1, and PKC pathways [69–71] |
|
Resveratrol |
Improve UACR, and increase production of antioxidant enzymes |
Inhibit caspase 3, TGF-β/Smad and ERK1/2 to reduce early glomerulosclerosis [73–76] |
|
Icariin |
Blood lipid-lowering, anti-aging, and anti-inflammation |
TLR4/NF-κB, Keap1/Nrf2, Col-IV/TGF-β1, miR-192-5p/GLR-1R [77–80] |
|
Silymarin |
Reduce UACR, urinary TNF-α, and MDA |
Protect against kidney fibrosis via the JAK/STAT3/SOCS1 and TGF-β1/Smad pathways [82–84] |
|
Curcumin |
Anti-oxidization and anti-inflammation |
Regulate Nrf2 to inhibit NF-κB, TGF-β1, CTGF, fibronectin and Col IV [85–88] |
|
Salvianolic acid |
Reduce blood glucose |
Suppress TNF-α and IL-6 [89] |
|
Safflower amine |
Inhibit platelet/neutrophil adhesion, decrease fibrosis [90] |
|
Polysaccharides |
Lycium barbarum polysaccharides |
Enhance activity of antioxidant enzymes and scavenge of oxygen radicals |
Decrease ERK 1/2 activation via the PKC pathway [91–93] |
|
Ramulus mori polysaccharides |
Dispel wind and activate collaterals, ease joint movement, dry dampness and alleviate water retention, regulate glycolipid metabolism, and improve the body’s immune function |
Up-regulate the expression of SIRT1 and FoxO1 proteins and decrease NF-KB to resist oxidative stress [94] |
|
Chinese yam polysaccharides |
Elevate insulin level, decrease glucagon level and FBG |
Enhance multiple anti-oxidative stress pathways including the PI3K [95] |
Alkaloids |
Berberine |
Reduce UER, FBG, HbA1c and GPx |
Regulate the expression of GRKs in the G protein-AC-cAMP signaling pathway [99–104] |
|
Ligustrazine |
Reduce 24-h UP, blood glucose, and BUN |
Anti-oxidative stress, anti-inflammation, and anti-fibrosis [106–107] |
Saponins |
Astragalosides |
Alleviate albuminuria and glomerulosclerosis, and simultaneously inhibit podocyte apoptosis and recover impaired autophagy |
PI3K/Akt/FoxO1, AMPK and SIRT/NF-κB signaling pathways [108–116] |
|
Paeoniflorin |
Reduce UAER |
Alleviate oxidization and inflammation through the TLR2/4 and JAK2/STAT3 pathways, up-regulate p-mTOR level to promote autophagy [117–119] |
|
Ginsenoside |
Reduce blood glucose and lipid levels, improve oxidative stress |
Akt/GSK-3β, PI3K/Akt, TGF-β1/Smad [121–126] |
|
Notoginsenoside |
Reduce FBG, Ccr, UAlb and kidney index |
Enhance BMP-7 and Smad7 via inhibiting VEGF and TGF- β1 [127] |
Other |
Emodin
|
Reduce 24-h UP |
Regulate the AMPK/mTOR-mediated autophagy and activate the PI3K/Akt/GSK-3β pathway to inhibit inflammation [128–131] |